Cdkn2btm3Nki
Targeted Allele Detail
|
|
| Symbol: |
Cdkn2btm3Nki |
| Name: |
cyclin dependent kinase inhibitor 2B; targeted mutation 3, The Netherlands Cancer Institute |
| MGI ID: |
MGI:5560509 |
| Synonyms: |
Cdkn2a/Cdkn2btm3Nki |
| Gene: |
Cdkn2b Location: Chr4:89224536-89229276 bp, - strand Genetic Position: Chr4, 42.15 cM, cytoband C3-C6
|
| Alliance: |
Cdkn2btm3Nki page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:273283
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Targeted (Conditional ready, No functional change) |
| Mutations: |
|
Insertion, Intragenic deletion
|
| |
|
Cdkn2b was replaced by Hyg followed 3' by loxP. This allele was generated in ES cells. (J:273283)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Cdkn2b Mutation: |
7 strains or lines available
|
|
| Original: |
J:273283 Krimpenfort P, et al., A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis. Nat Commun. 2019 Mar 29;10(1):1425 |
| All: |
1 reference(s) |
|
Analysis Tools